A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

Following the weekend data presentation, Citizens voiced optimism regarding CRISPR’s in-vivo projects. The firm noted some ...

Key breakthrough for the return of the dodo: viable cells have been obtained and genetically modified birds have been prepared.

The Minister noted that with the development and transfer of India's first indigenous CRISPR-based gene therapy, the nation ...

New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.

Oppenheimer emphasized the advancements in CRISPR’s in vivo initiatives, highlighting the comprehensive findings from the ...

Nearly 40% of respondents identified AI-based frameworks as their top priority for reducing cyber risk over the next three ...

From 2017 until Oct. 1, 2025, sponsors have submitted around 50 INDs seeking to begin clinical testing of individualized ...

Utilizing the gene-editing technology CRISPR, researchers have found a way to combat chemoresistance in lung cancer cells, restoring hope for patients. Shannon Horning/ SciTech Editor For patients ...

After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the ...